Medicare’s Prescription Drug Plan Makeover
An overhaul of Medicare’s prescription drug benefit will lower costs for seniors while changing incentives for insurers and drugmakers.
Therese Humphrey Ball, Multiple sclerosis patient and advocate.
Juliette Cubanski, Deputy Director for Program on Medicare Policy at the Kaiser Family Foundation.
Learn more and read a full transcript on our website.
Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.
Support this type of journalism today, with a gift.
Hosted on Acast. See acast.com/privacy for more information.